Lead Product(s) : Undisclosed
Therapeutic Area : Dermatology
Study Phase : Discovery Platform
Sponsor : Almirall
Deal Size : Undisclosed
Deal Type : Collaboration
HitGen and Almirall Announce Achievement of Milestoneinn their Strategic Collaboration
Details : Multiple small molecule leads for an undisclosed target nominated by Almirall were the subject of this achievement. HitGen will grant exclusive rights to Almirall for further development and commercialization, and be eligible for preclinical and clinical...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 26, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Dermatology
Highest Development Status : Discovery Platform
Sponsor : Almirall
Deal Size : Undisclosed
Deal Type : Collaboration